Wednesday, October 7, 2026

How We Source Explore Search

Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

Press releaseGlobeNewswire· March 28, 2026

Tribal Loans Are On The Rise — And TribalLoans.com Might Be the Reason Why

View original at globenewswire.com

Tribal Loans Are On The Rise — And TribalLoans.com Might Be the Reason Why New York, NY, March 27, 2026 (GLOBE NEWSWIRE) -- Let's be honest…

Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

Platform runs only soft credit inquiry that won't leave a mark on credit file
60% confidence
Application process takes around two minutes
60% confidence
Approved applicants can receive funds via ACH transfer on the day they apply
60% confidence
Platform has a 4.9 out of 5 customer rating
60% confidence
TribalLoans.com has served over 2,000,000 borrowers across the US
60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page

Live from the substrate

What we're seeing

Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave

Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.

Our read on the data ›

Signals we're tracking

Satellite-Terrestrial Network Integration Acceleration

Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases

Patterns we're watching ›

Where sources disagree

ING Group

Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.

We flag conflicts openly ›

Recently verified

✓ Checked against the original source

4,985

facts traced to their source — and we flag the ones that don't hold up.

101 entities tracked4,985 facts checked against source5,351 source documents archived

Query this data → isubstrate.com